Cue Biopharma Inc (NASDAQ: CUE) is -30.09% lower on its value in year-to-date trading and has touched a low of $0.45 and a high of $2.26 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CUE stock was last observed hovering at around $0.78 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $0.76, the stock is -6.92% and -26.95% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.11 million and changing -2.18% at the moment leaves the stock -27.13% off its SMA200. CUE registered -49.03% loss for a year compared to 6-month loss of -31.96%. The firm has a 50-day simple moving average (SMA 50) of $1.04316 and a 200-day simple moving average (SMA200) of $1.045695.
The stock witnessed a -21.38% gain in the last 1 month and extending the period to 3 months gives it a -40.47%, and is 6.01% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.06% over the week and 12.90% over the month.
Cue Biopharma Inc (CUE) has around 41 employees, a market worth around $47.11M and $9.29M in sales. Profit margin for the company is -437.97%. Distance from 52-week low is 69.33% and -66.28% from its 52-week high. The company has generated returns on investments over the last 12 months (-219.84%).
The EPS is expected to grow by 17.36% this year
71.0 institutions hold shares in Cue Biopharma Inc (CUE), with institutional investors hold 15.70% of the company’s shares. The shares outstanding are 61.82M, and float is at 61.35M with Short Float at 1.39%. Institutions hold 15.62% of the Float.
The top institutional shareholder in the company is BLEICHROEDER LP with over 2.86 million shares valued at $3.55 million. The investor’s holdings represent 5.7849 of the CUE Shares outstanding. As of 2024-06-30, the second largest holder is SLATE PATH CAPITAL LP with 2.4 million shares valued at $2.98 million to account for 4.8567 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 2.03 million shares representing 4.1066 and valued at over $2.52 million, while BLACKROCK INC. holds 1.5298 of the shares totaling 0.76 million with a market value of $0.94 million.
Cue Biopharma Inc (CUE) Insider Activity
The most recent transaction is an insider purchase by PASSERI DANIEL R, the company’s CHIEF EXECUTIVE OFFICER. SEC filings show that PASSERI DANIEL R bought 30,000 shares of the company’s common stock on Dec 16 ’24 at a price of $1.03 per share for a total of $30900.0. Following the purchase, the insider now owns 0.16 million shares.
